Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications leukemia risk children exposed benzene pm10 vehicular traffic case–control study
RTI-HS Researchers Outline Best Practices for Collecting Patient Experience Data During the COVID-19 Outbreak Share on: April 9, 2020 Updated November 10, 2020 Experts on our Patient-Centered Outcomes Assessment (PCOA) team collaborated to create this …
… care resources and face higher costs than patients who can control their condition with anti-epileptic drugs (AEDs). … at RTI Health Solutions and LivaNova, PLC conducted a study to understand the long-term significance of these costs …
… covering 2 annual preventative oral health visits for low-risk adults aged 18 to 64. She has experience building Markov …
… system programming, comprehensive testing, monitoring study progress, and adeptly addressing and identifying …
Forbes Magazine Recognizes RTI International as One of the Best Employers for Diversity Share on: April 26, 2024 The 2024 America’s Best Employers for Diversity rankings resulted from surveying 170,000 US employees RESEARCH TRIANGLE PARK, N.C. — …
Amanda Di Rosa Market Access and Outcomes Strategy Telecommuter - USA PhD, Global Public Health Queen Margaret University, Edinburgh, United Kingdom MSc, Psychology & Health City University, London, United Kingdom BA, Creative Writing and Cinema and …
… post authorization safety studies (PASS), risk evaluation and mitigation strategy (REMS) assessment … diseases. Ms. Sweeney's project experience includes study design and implementation protocol development, … or subcontractors, review of documentation for quality-control purposes, literature reviews, and analysis and …
… research and medical writing, including developing study designs, supporting study execution, analyzing quantitative and qualitative data, …
… studies, epidemiologic studies, patient outcomes research, risk-management program evaluations, and patient registries. …
Tailoring Cost-Effectiveness Modeling Methodologies for Multiple Sclerosis Comparative effectiveness and cost-effectiveness of natalizumab and fingolimod in patients with inadequate response to disease-modifying therapies in relapsing-remitting multiple …